Search results for CHD3 antibody

CHD3 antibody, Genetex, GTX131779

CHD3 Antibody (YA944), MedChemexpress, HY-P81264

CHD3 Antibody (YA944) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CHD3.

CHD3 Antibody (YA945), MedChemexpress, HY-P81264A

CHD3 Antibody (YA945) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CHD3.

CHD3 Antibody#4241, Cell Signaling Technology (CST), 4241

CHD3 Antibody detects endogenous levels of total CHD3 protein.

CHD3 antibody [2G4], Genetex, GTX83232

Anti-CHD3 Antibody (R3R87), AntibodySystem, RHG31802

Anti-CHD3 Antibody (R3R88), AntibodySystem, RHG31803

Anti-CHD3 antibody [EPNCIR110], Abcam, AB134125

Species reactivity Human, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . Collaborations This antibody was developed as part of a collaboration between Epitomics, the National Cancer Institute's Center for Cancer Research and the lab of Gordon Hager. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CHD3 antibody [EPNCIR110A], Abcam, AB109195

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . Collaborations This antibody was developed as part of a collaboration between Epitomics, the National Cancer Institute's Center for Cancer Research and the lab of Gordon Hager. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

HRP Anti-CHD3 antibody [EPNCIR110A], Abcam, AB306366

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .